A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples